AI ASSISTANT
Ask DrugCentral
Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Try a sample question
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
ornipressin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| vasopressin analogues | 4679 | 3397-23-7 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A synthetic analog of vasopressin with ORNITHINE substitution at residue 8 of the cyclic nonapeptide. It is used as a local vasoconstrictor and hemostatic.
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 5 | U | P |
ADMET properties:
None
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2B,BRAF,CAMK2D,CDK5,EIF2AK3,GRK2,ITK,PDK1,PDK2,PDK4,PRKDC | 11 | |||
| kinase-selectivity-class | GRK2 | 1 | |||
| mdck-mdr1-bcrp-efflux | MDCK-MDR1-BCRP efflux ratio | 1.589 | Moderate | 0.78 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | H01BA05 | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES POSTERIOR PITUITARY LOBE HORMONES Vasopressin and analogues |
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D003029 | Coagulants |
| MeSH PA | D006401 | Hematologic Agents |
| MeSH PA | D006490 | Hemostatics |
| MeSH PA | D014662 | Vasoconstrictor Agents |
Related Drugs by ATC class:
H01BA Vasopressin and analogues 4 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.47 | acidic |
| pKa2 | 12.33 | acidic |
| pKa3 | 12.66 | acidic |
| pKa4 | 12.81 | acidic |
| pKa5 | 13.19 | acidic |
| pKa6 | 13.28 | acidic |
| pKa7 | 13.55 | acidic |
| pKa8 | 13.68 | acidic |
| pKa9 | 10.12 | Basic |
| pKa10 | 6.4 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D07227 | KEGG_DRUG |
| N0000170338 | NUI |
| CHEMBL1819440 | ChEMBL_ID |
| 2544 | INN_ID |
| DB13464 | DRUGBANK_ID |
| 1KTH6N080W | UNII |
| 7703 | RXNORM |
| 006913 | NDDF |
| 703839000 | SNOMEDCT_US |
| C0029276 | UMLSCUI |
| D009951 | MESH_DESCRIPTOR_UI |
| CHEBI:136020 | CHEBI |
| 14257660 | PUBCHEM_CID |
| 1KTH6N080W | INXIGHT DRUGS |
Pharmaceutical products:
None